Developmentally Adapted Cognitive Processing Therapy for Adolescents and Young Adults with PTSD Symptoms after Physical and Sexual Abuse

Not Applicable

• Conditions: DSM-IV: 309.81 - Posttraumatic Stress Disorder; F43.1; Post-traumatic stress disorder

• Registration Number: DRKS00004787
• Lead Sponsor: Katholische Universität Eichstätt-Ingolstadt;Lehrstuhl Klinische und Biologische Psychologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-03-18
• Study Completion: 2016-08-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

Sexual or physical abuse after the age of three (definition according to the American Psychological Association Committee on Professional Practice and Standards, 1999)
PTSD (according to CAPS-CA: meeting 1 B-criterion, 2 C-criteria, 2 D-criteria) persisting for longer than one month
PTSD as primary diagnosis
Living in safe conditions
Sufficient knowledge of German language
Informed consent from parents/legal guardians (if under 18) and participant
Stable psychopharmacological medication at study entry (in the last 3 weeks there was either no or a constant psychopharmacological medication)

Exclusion Criteria

Acute suicidality within the last 6 months
Life threatening self-harming behavior within the last 6 months
Substance related or organic mental disorder
Pervasive developmental disorder
Current or lifetime diagnosis of a psychotic disorder according to DSM-IV
Current or lifetime diagnosis of a bipolar disorder according to DSM-IV
Current diagnosis of substance dependence according to DSM-IV (abstinence < 6 months)
Mental retardation (IQ = 75)
Simultaneous psychotherapeutic treatment

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of PTSD <br>Measure: German version of the Clinician Administered PTSD Scale for Children and Adolescents (CAPS-CA, in German IBS-P-KJ; Steil & Füchsel, 2006)<br>Measurement points: Pretest (before starting the treatment), Posttest (after ending the treatment, approx. 16 weeks), Follow-Up I (3 months after ending the treatment), Follow-Up II (6 months after ending the treatment; for patients of the TAU-arm only those, who didn’t choose D-CPT after Follow-Up I)